Physician profile
Manisha Sethi
NPI 1316046410
$1,929.63
in general payments reported to CMS, 2019-2025
20 companies · $210 in 2025
The $210 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $70.73 · 2023: $139 · 2024: $1,300 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,104 · Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,104.00 |
| Food and Beverage | $544.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $1,104.00 | 2024 | |
| Novo Nordisk INC | $153.58 | 2023-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $143.45 | 2019-2025 | |
| Abbvie INC. | $106.00 | 2019-2025 | Ubrelvy, Synthroid |
| Sanofi Pasteur INC. | $70.20 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $61.98 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaqta |
| Takeda Pharmaceuticals U.S.A., INC. | $52.87 | 2019-2020 | |
| Tris Pharma INC | $33.64 | 2019 | |
| Ironshore Pharmaceuticals INC. | $31.71 | 2019 | |
| Lilly USA, LLC | $28.27 | 2024 | Mounjaro |
| Abbott Laboratories | $19.73 | 2023 | Freestyle Libre 2 |
| Amgen INC. | $15.51 | 2020 | |
| Genentech USA, INC. | $15.11 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.06 | 2019 | |
| Seqirus USA INC | $13.70 | 2024 | Fluad, Flucelvax |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.63 | 2019 | |
| Adlon Therapeutics L.P. | $13.40 | 2020 | |
| Shire North American Group INC | $13.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.40 | 2019 | |
| Sobi, INC | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.